The Board of Directors of Becton, Dickinson & Co. has authorized the company's management to begin spinning off the diabetes business into a separate public company, NewCo. Its shares are planned to be distributed to BD shareholders. The spin-off is expected to be completed in the 2nd half of 2022.
Warning BlackTerminal uses cookies in order to personalize and improve the usability of the service. If you do not want to use cookies, please change your browser settings. Accept